scholarly article | Q13442814 |
P50 | author | Laura Via | Q42667576 |
Edward Jones Lopez | Q42840002 | ||
Clifton E Barry | Q51118358 | ||
P2093 | author name string | David Alland | |
Jong Seok Lee | |||
Yang Dai | |||
Soo-Hee Hwang | |||
Alifiya S Motiwala | |||
Sang Nae Cho | |||
P2860 | cites work | Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update | Q28143206 |
Extensively drug-resistant tuberculosis | Q28238036 | ||
Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa | Q28272340 | ||
Secreted transcription factor controls Mycobacterium tuberculosis virulence | Q28487057 | ||
Role of large sequence polymorphisms (LSPs) in generating genomic diversity among clinical isolates of Mycobacterium tuberculosis and the utility of LSPs in phylogenetic analysis | Q30479107 | ||
Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance | Q33935393 | ||
Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans. | Q34131132 | ||
Global phylogeny of Mycobacterium tuberculosis based on single nucleotide polymorphism (SNP) analysis: insights into tuberculosis evolution, phylogenetic accuracy of other DNA fingerprinting systems, and recommendations for a minimal standard SNP se | Q34303290 | ||
Comparative and functional genomics of the Mycobacterium tuberculosis complex | Q34943266 | ||
Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. | Q34973711 | ||
Convergent evolutionary analysis identifies significant mutations in drug resistance targets of Mycobacterium tuberculosis. | Q36870821 | ||
Fitness cost of drug resistance in Mycobacterium tuberculosis | Q37394245 | ||
Transfer of embB codon 306 mutations into clinical Mycobacterium tuberculosis strains alters susceptibility to ethambutol, isoniazid, and rifampin | Q38898564 | ||
The competitive cost of antibiotic resistance in Mycobacterium tuberculosis | Q40311130 | ||
Tuberculosis. Few mutations divide some drug-resistant TB strains | Q81573588 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Mycobacterium tuberculosis | Q130971 |
P304 | page(s) | 881-888 | |
P577 | publication date | 2010-03-01 | |
P1433 | published in | Journal of Infectious Diseases | Q4051141 |
P1476 | title | Mutations in extensively drug-resistant Mycobacterium tuberculosis that do not code for known drug-resistance mechanisms | |
P478 | volume | 201 |
Q42716800 | Antibacterial, antifungal and antileishmanial activities of indolone-N-oxide derivatives. |
Q28486275 | Comparative genomic analysis of Mycobacterium tuberculosis drug resistant strains from Russia |
Q45926221 | Complex genetics of drug resistance in Mycobacterium tuberculosis. |
Q33905492 | Detecting novel genetic variants associated with isoniazid-resistant Mycobacterium tuberculosis |
Q36368678 | Dynamic population changes in Mycobacterium tuberculosis during acquisition and fixation of drug resistance in patients |
Q34410451 | Extensively Drug-Resistant Tuberculosis: A Sign of the Times and an Impetus for Antimicrobial Discovery |
Q28389409 | Methodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other Mycobacteria |
Q28537876 | Reduced virulence of an extensively drug-resistant outbreak strain of Mycobacterium tuberculosis in a murine model |
Q89738388 | SEVERITY OF TB CLASSIFIED BY MODIFIED BANDIM TB SCORING ASSOCIATES WITH THE SPECIFIC SEQUENCE OF ESXA GENES IN MDR-TB PATIENTS |
Q37683485 | The impact of drug resistance on Mycobacterium tuberculosis physiology: what can we learn from rifampicin? |
Q41577313 | ubiA (Rv3806c) encoding DPPR synthase involved in cell wall synthesis is associated with ethambutol resistance in Mycobacterium tuberculosis |